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Abstract Myotonic dystrophy type 1 (DM1) is the most
frequent inherited neuromuscular disorder. The juvenile
form has been associated with cognitive and psychiatric
dysfunction, but the phenotype remains unclear. We
reviewed the literature to examine the psychiatric pheno-
type of juvenile DM1 and performed an admixture analysis
of the IQ distribution of our own patients, as we hypoth-
esised a bimodal distribution. Two-thirds of the patients
had at least one DSM-IV diagnosis, mainly attention
deficit/hyperactivity disorder and anxiety disorder. Two-
thirds had learning disabilities comorbid with mental
retardation on one hand, but also attention deficit, low
cognitive speed and visual spatial impairment on the other.
IQ showed a bi-modal distribution and was associated with
parental transmission. The psychiatric phenotype in juve-
nile DM1 is complex. We distinguished two different
phenotypic subtypes: one group characterised by mental
retardation, severe developmental delay and maternal
transmission; and another group characterised by border-
line full scale IQ, subnormal development and paternal
transmission.
Keywords Myotonic dystrophy type 1  Juvenile form 
Psychiatric phenotype  Cognitive profile
Introduction
Myotonic dystrophy 1 (DM1), also called Steinert disease,
dystrophic myotonia or myotonic muscular dystrophy, is a
progressive neuromuscular disease caused by a genetic
mutation and characterised by a wide variation in neu-
romuscular symptoms and multisystem involvement. DM1
is the most frequently inherited neuromuscular disease,
with autosomal dominant transmission. The incidence rate
estimate is 1/8,000 [1], although the actual rate is prob-
ably higher due to the poor recognition of minor or
atypical forms of the disease. Darin et al. [2] estimated
the point prevalence in the population under 16 years to
be about 5 per 100,000. DM1 is caused by an expanded
and unstable CTG repeat sequence in the 30 untranslated
region of the DMPK gene located on the long-arm of
chromosome 19. The gene’s sequence belongs to the
protein kinase family [3–5]. The CTG repeat ranges from
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5 to 37 in the general population, while in DM1 it
exceeds 50 and can increase to several thousand units.
Progressive expansion of CTG amplification appears both
meiotically and mitotically unstable, and is biased toward
amplification. This explains both the anticipation phe-
nomenon observed in DM1 pedigrees and the variable
clinical expression amongst affected individuals [6]. Type
2 myotonic dystrophy is caused by the mutation of a
different gene (ZNF9) and tends to be much milder than
DM1.
Myotonic dystrophy type 1 in adults is characterised by
myotonia and muscular weakness, but other symptoms
can be present depending on the affected organ system.
These symptoms include cataracts, smooth muscle dis-
turbances (oesophageal spasms, spastic colon, diarrhoea),
gonadal dysfunction in males (subfertility), mental retar-
dation, depression, somnolence, diabetes and cardiac
conduction defects (bradycardia, arrhythmias) [7]. Initially
considered a peripheral neurological disease, the
involvement of the central nervous system in DM1 is now
well established. The course of DM1 is marked by
hypersomnia, loss of initiative, apathy and cognitive
dysfunction (visual spatial and memory deficits) that
increase with age. Considering its clinical manifestations
and the age of onset, Harley et al. [6] proposed four types
of DM: (1) a mild form with cataracts and no or minimal
muscular symptoms in middle or older age; (2) a classical
form with typical neuromuscular symptomatology in
adolescence or early adult life; (3) a juvenile form with
learning disabilities often prominent in early life (before
the age of 10 years), but with mild, or sometimes even
absent, neuromuscular signs at first diagnosis; (4) a con-
genital form with clinical symptoms present at birth or in
utero: hypotonic cerebral palsy, facial diplegia, respiratory
and feeding problems and mild to moderate mental
retardation in survivors. The congenital form is usually
caused by maternal transmission, although a few excep-
tions have been reported [8].
There have been numerous reports on the somatic signs
associated with juvenile DM1, which include difficulties in
mastication, deglutition and elocution, smooth muscle
disturbances, cardiac conduction defects (bradycardia,
arrhythmias), hypofertility and diabetes [9]. However, to
date, only a limited number of studies have been conducted
on the clinical psychiatric phenotype of juvenile DM1.
The aim of the current report is to clarify the pheno-
type of the juvenile form of DM 1 by (1) reviewing the
literature on the psychiatric phenotype, (2) evaluating
more precisely the association between IQ and DM1 by
performing an admixture analysis of IQ distribution in our
own patients, as we hypothesised a bimodal distribution
related to the transmitting parent [10], (3) summarising
two paradigmatic clinical vignettes focusing on differen-
tial diagnosis.
Methods
First to review the scientific literature regarding psychi-
atric and cognitive disorders in juvenile myotonic dys-
trophy, a systematic search of the MEDLINE database
over the period of January 1960 to September 2008 was
conducted with the following keywords: myotonic dys-
trophy or Steinert disease and childhood, yielding 70
articles. Figure 1 summarises the literature search. We
screened the abstracts and selected those articles focusing
on the cognitive and psychiatric aspects of the juvenile
form of DM1. Most of the papers focused on the somatic
aspects of the disease (N = 39), did not distinguish con-
genital from juvenile DM1 (N = 3), or were not relevant
(N = 9), and were therefore excluded. We reviewed the
reference lists of the selected papers to improve the lit-
erature search and found four additional articles. Three
articles had no English abstract and were excluded.
Finally, we collected 19 articles: 12 case reports [11–21],
one study focusing on vigilance and sleep disorders and
six studies on the cognitive and psychiatric phenotype of
DM1 (Table 1) [22–27].
Second, we hypothesised a bimodal distribution of
phenotype related to the transmitting parent. This a priori
hypothesis was based on the several facts. (1) In a previous
study, we performed on reading and spelling impairments
in patients with juvenile DM1 [10], we showed that reading
and spelling impairments also occurred in subjects with
normal IQ and were correlated with parental transmission.
(2) In genetic diseases, parental transmission and imprint-
ing effects are often associated with a bimodal distribution
of phenotypes. The more obvious example in child psy-
chiatry is the proximal duplication of chromosome 15q that
is associated with autism when the duplicated material is
transmitted by the mother [28]. (3) The bimodal distribu-
tion of IQ in Tuberous Sclerosis, another genetic disease
with a large phenotype, has been recently evidenced by
Winterkorn et al. [29].
Admixture analysis allows testing the assumption that
the sample (or observed distribution of the variable)
contains several subpopulations by modelling a mixture of
distinct multivariate normal distributions. We can identify
the number of subpopulations that best fit the observed
data and estimate for each of them the characteristics of
the distribution (mean and standard error). For example,
using this method in samples of bipolar patients, it has
been shown that there may be distinct age at onset sub-
groups amongst bipolar patients [30], and that within
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Articles identified in MEDLINE database 
From January 1960 to February 2008
Key-words: myotonic dystrophy and childhood
(N=70) 
Excluded:
Not relevant (N=9)
Only genetic, epidemiologic, somatic data 
(N=39)
Adult form (N=1)
Congenital or not distinguishing between 
congenital and juvenile form (N=3)
Juvenile form of DM1
Cognitive and psychiatric disorders
(N=18)
Additional studies from bibliography 
(N=4) Excluded:
No English available abstract (N=3)
Case reports
(N=12)
Studies
(N=7)
Fig. 1 Diagram flow of the
literature search
Table 1 Design and main methodological characteristics of the selected studies
References N (age) % Male Mat/pat Inclusion criteria Cognitive instruments Psychiatric
instruments
Steyaert et al. [22] 14 (7–18) 44 10/4 Congenital/juvenile DM1, clinical
setting
WISC-R
WAIS
CBCL
ADIKA
Goosens et al. [23] 24 (9–22) 58 13/11 Juvenile DM1, failure at primary
school, clinical setting
WISC-R
WAIS
CBCL
ADIKA
Quera-Salva et al. [26] 21 (16 ± 3) 57 ? Juvenile DM1, sleep or vigilance
comorbidity, clinical setting
Sleep questionnaire
Night-time
polysomnography
Cohen et al. [10]a 23 (8–18) 61 12/11 Subgroup of Angeard et al. WISC-III
Phonology
Word identification
Global reading
Spelling
Learning disability
questionnaire
Angeard et al. [24] 36 (6–18) 55 21/15 Juvenile DM1, paternal–maternal
transmission, clinical setting
WISC-III
Echenne et al. [25] 15 (8–23) ? ? Congenital/juvenile DM1, clinical
setting, long-term follow-up
WISC-R Clinical description
without systematic
instruments
Ekstro¨m et al. [27]a 18 (8–21) 44 13/5 Congenital/juvenile DM1,
clinical setting
WISC-III
WAIS III
ADI-R
SCQ
FTF
DM1 dystrophic myotony 1, CBCL child behaviour check list, WISC-R Wechsler intelligence scale-revised, WAIS Wechsler adult intelligence
scale, ADI-R Autism diagnostic interview, FTF ‘‘Five to Fifteen’’ parental questionnaire, ADIKA Amsterdam diagnostisch interview voor
Kinderen, SCQ social communication questionnaire, ? not reported
a The study included 57 subjects, but only 18 with the juvenile form
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bipolar disorder associated with Cotard syndrome, early
versus late onset should be distinguished [31]. Therefore,
to assess our hypothesis, we collected IQ scores from the
study of Angeard et al. as this sample was characterised
by an equivalent number of patients with maternal and
paternal transmission (see details below), and we per-
formed an admixture analysis to determine the best fitting
model for IQ scores in juvenile DM1. Finally, we reported
two cases evaluated in our specialised clinics illustrating
different aspects of the disease and possible psychiatric
differential diagnosis.
Results
General comments
Despite the frequency of the disease and the prevalence of
learning disabilities, we found very limited data related to
psychiatric phenotype of DM1: 12 case reports and 7
studies. The classification of Harley et al. [6] was relatively
recent (1993), and some articles identified using the liter-
ature search could not be exploited as they failed to dif-
ferentiate between the juvenile and congenital forms of
DM1. The remaining case reports were all published more
than 10 years ago and represented the assessment of 31
children and adolescents. The seven studies [10, 22–27]
were conducted by five groups—Steyaert and Goosens in
Belgium; He´ron and Eymard, Echenne and Quera Salva in
different French settings; and Ekstro¨m in Sweden—and
included 114 children and adolescents. In total, the current
review summarises the data for 145 children and
adolescents.
Before summarising the study results, methodological
issues should be considered. The design and methodo-
logical characteristics of each study are presented in
Table 1. As shown in the table, no study was exhaustive.
Most studies evaluated general cognitive abilities, but only
two had a systematic assessment of axis 1 psychiatric
disorders (Steyaert, Goosens). One study focused on
reading and spelling impairments (Cohen), one focused on
autistic symptoms (Ekstro¨m) and one evaluated sleep and
vigilance impairments using polysomnography (Quera
Salva). Studies were also heterogeneous with respect to
inclusion criteria, with a tendency for recruiting patients
with maternal transmission—that is to say, more severe
phenotypes. Finally, only one study included data on the
symptomatic course and outcome of the disease (Echenne).
Based on this review, on both previous single case
descriptions and on our own experience (Cases 1 and 2),
we propose to classify the psychiatric phenotype into three
symptom groups: (1) general cognitive functioning, (2)
developmental delay and learning disabilities, (3) psychi-
atric symptoms.
General cognitive functioning
The individual full scale IQ varied across the studies from
42 to 114, but the mean IQ was globally similar, 69.75–80,
which is in the borderline range (Table 2). Twenty-three
patients amongst the 31 single case reports had mental
retardation [11, 14–17, 19, 20]. Analysis of the Wechsler
subscales showed no difference between the average per-
formance IQ (PIQ) and the average verbal IQ (VIQ) in the
studies of Steyaert et al. [22] and Goosens [23], but in the
largest study [24], a significant difference was found
between VIQ and PIQ (Table 2): a 10-point discrepancy,
required for establishing clinical difference at the 0.05
level, was found in 16 of 36 subjects (44%), with no dif-
ference between the two inheritance groups. These results
Table 2 General cognitive functioning in juvenile DM1
Steyaert
(N = 16)
Goosens
(N = 24)
Angeard
(N = 36)
Echenne
(N = 15)
Ekstrom
(N = 18)
Full IQ range 62–95 50–97 42–114 47–85 \70: 89%a
Full IQ mean (SD) 80 72.25 (14) 69.75 (19.1) Median: 61
Performance IQ mean (SD) 82 68.7 (15.8) Median: 60.5
Verbal IQ mean (SD) 79 76.4 (20.9) Median 68.5
Dissociation VIQ/PIQ NS NS P \ 0.0001
Genotype/phenotype correlates
Correlation CTG repeat/full IQ score ? P \ 0.05 ? P \ 0.0001
Maternal/paternal transmission N = 10/4 N = 13/11 N = 21/15 N = 13/5
Association parental inheritance mode/full IQ score P = 0.034 P = 0.001 P \ 0.001
DM1 dystrophic myotony 1, IQ intellectual quotient, VIQ verbal IQ, PIQ performance IQ
a IQ \ 50: 50%; 50 \ IQ \ 70: 39%; 70 \ IQ \ 85: 5.5%; IQ [ 85: 85%
708 Eur Child Adolesc Psychiatry (2009) 18:705–715
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were confirmed in Cohen’s study [10], with a significant
difference between VIQ and PIQ in subjects without
mental retardation.
The analysis of the effect of the CTG repeat number led
to the same results in all studies. The expansion lengths
correlated with the transmitting parent’s sex; inheritance
from the mother gave a longer expansion length than that
from the father. In addition, a significant effect of the
transmitting parent’s sex on the IQ scores of the affected
child was found [10, 22–24, 27]. Moreover, significant
correlations between IQ scores and the CTG repeat number
were established [24, 27].
Some case reports showed that some individuals exhib-
ited cognitive decline over time [11, 20, 22]. Echenne et al.
[25] assessed this issue by repeated IQ evaluation of eight
patients with juvenile DM1. Three children showed stable
results over time, and five showed a slight or a marked
decline in full scale IQ 1–5 years later. Angeard et al. [24]
analysed intra-scalar IQ scores, within groups divided
according to inheritance transmission. Subjects with
maternal inheritance had the best scores in VIQ. However,
most subjects had scores inferior to 1SD compared with
age-paired norms (mean intra-scalar subscores ranging
from 3.85 to 5.85). Subjects with paternal transmission had
normal VIQ, although average intra-scalar subscores fell in
the borderline zone (between 7.8 and 8.53). Patients pre-
sented their lowest PIQ scores in the object assembly
(mean = 2.85 and 6.67 for maternal and paternal trans-
mission, respectively) and block design tasks (2.6 and 3.93,
for maternal and paternal transmission, respectively). These
subtests had a strong inter-subtest correlation, indicating a
probable visual spatial deficit.
Developmental delay and learning disabilities
Although not evaluated in clinical series, several case
descriptions reported that children with DM1 sometimes
exhibited early motor development delay (sitting without
support after 8 months, walking alone after 18 months),
hypotonia and motor coordination impairments [16, 20, 21,
23]. Others showed speech and language delay [18, 19].
Echenne et al. [25] found that 73.3% (11/15) of DM1
patients investigated had speech or language delay as an
isolated manifestation until adolescence. However, learn-
ing disabilities were the most prominent symptoms repor-
ted in juvenile DM1. School difficulties were particularly
common with 69–86.7% of patients being academically
delayed [10, 23, 25]. Goosens et al. [23] reported that of the
21 patients who attended school, only 4 subjects were in a
normal school programme, whereas 17 (81%) subjects
were in a special education programme (11 for children
with mild mental retardation, 3 for children with learning
disabilities, 2 for motor disabled people and 1 for children
with moderate mental retardation). One subject worked in a
sheltered workshop.
Cohen et al. [10] investigated reading and spelling dif-
ficulties. Phonology, word identification efficacy score and
speed were all significantly lower in the subjects with low
verbal IQ (\76), than in regular French school students,
except for phonological sensitivity. As expected, subjects
with DM1 were all below their expected literacy levels for
reading tasks. In contrast, subjects with high verbal IQ did
not exhibit lower scores for either phonology or word
identification. However, they had difficulties in global
reading tasks and reading impairments were frequent. Most
of the patients had scores superior to the level of literacy
for age-matched subjects French people in the short prose
text task, but 55% of the patients exhibited difficulties with
the long prose text task, although this task was linguisti-
cally more simple. Sixty-six percent of the subjects with
normal IQ had difficulties extracting proper information in
a TV schedule task. Finally, 82% had moderate to severe
difficulties in spelling tasks. The severity of these learning
difficulties correlated with longer mutation length and with
maternal transmission, but could not be related to phono-
logical deficit. Furthermore, 16 (69%) subjects had or were
undergoing reading therapy, and some of these subjects
were in the high-cognitive group (63.6%).
Psychiatric disorders
Four studies systematically reported psychiatric impair-
ments, but only two used standardised instruments. Using
the CBCL parent form, Steyaert et al. and Goosens et al.
showed that 28.57% (Steyaert) to 42% (Goosens) of the
subjects’ scores were in the clinical range for total prob-
lems. Nearly 40% of the patients in both studies had in-
ternalising problems, whereas 6–8% scored in the clinical
range of the externalising subscale. On the separate
symptoms clusters, three main dimension mean scores
were found in the clinical range: ‘‘withdraw’’, ‘‘social
problem’’ and ‘‘attention problem’’, with reported fre-
quency of pathological scores of 29, 54 and 37%, respec-
tively [23]. No correlation between the IQ and CBCL total
problem score could be demonstrated. Similarly, no cor-
relation was found between CTG repeat mutation length
and CBCL total problem score.
Regarding psychiatric diagnosis, in the two studies that
used a structured interview, the majority of the patients had
an axis 1 DSM diagnosis (56.25% in Steyaert et al. and
63% in Goosens et al.). Attention deficit with hyperactivity
disorder (ADHD) was the most frequent diagnosis repor-
ted, with an average rate of 30% in both studies; signifi-
cantly higher than in the general population [24]. Goosens
[23] noticed that the inattentive subtype was the most
frequent. In Echenne’s study [25], where a standardised
Eur Child Adolesc Psychiatry (2009) 18:705–715 709
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instrument was not used, ADHD was found in 26% of the
patients but was not the most frequent diagnosis. Conduct
disorder was reported in 40% of the patients, but these
results contrasted with the more detailed descriptions of
these children found in case reports, where they were
described as apathetic and quiet [11, 12, 14]. In Ekstrom’s
study [27], only 11% of patients had ADHD, whereas
16.7% of patients (3/18) had an autistic disorder. In this
series, which also included both severe (N = 19) and mild
(N = 18) congenital forms of DM1, it was reported that the
more severe the type of DM1, the higher the frequency of
autism. As noted by the authors, none of the individuals
exhibited self-injurious behaviours, and problems in the
area of restricted, repetitive and stereotyped patterns of
behaviour were very limited. In addition, three cases of
Asperger syndrome were also reported [20, 21, 23]. The
second most frequent diagnosis was anxiety disorder,
diagnosed in 18.75% of patients in Steyaert et al. and 25%
in Goosens et al. [22, 23]. Different types of anxiety were
observed: generalised anxiety, separation anxiety and
specific phobia. Other diagnoses were noticed in lower
proportions: maladjustment disorder with depressive mood,
enuresis disorder and encopresis disorder.
Finally, the study of Quera Salva et al. [26] found an
important prevalence of sleep disorders in DM1 patients.
Seventy six percent of children reported fatigue and 52%
reported somnolence. Polysomnography evidenced that
sleep was disturbed by numerous micro arousals caused by
abnormal respiratory events in 26.8% of the children.
Furthermore, 38% presented periodic limb movements, and
29% suffered from a sleep apnoea syndrome.
Admixture analysis of IQ distribution
To clarify whether two distinguishing subgroups could be
established, we did an admixture analysis of the distri-
bution of the IQ scores of the 36 patients of Angeard’s
series (see main characteristics of the study in Tables 1,
2). Our analysis confirmed that patients could be divided
into two groups. We found two normal distributions of
IQ scores (Fig. 2). The mean IQ scores estimated in this
model were 58 (SD = 9) and 91 (SD = 13), dividing
patients into two groups: one with normal intelligence
and one with mild mental retardation. The likelihood
ratio test indicated that the model with two distributions
fit the observed distribution of IQ significantly better
than the model with one distribution (v2 = 9.45, df = 3,
P = 0.024). No further improvement was obtained with a
three component model.
Discussion
Myotonic dystrophy type 1 is the most frequent inherited
neuromuscular disease. The juvenile form is characterised
by the rarity or the absence of the classical neurological or
motor symptoms and by the presence of cognitive or psy-
chiatric symptoms; often the first signs of the disease,
which lead parents to consult with a specialist in a child
psychiatric setting. Reviewing the literature showed that
few systematic studies have been conducted on this aspect
of the disease despite the importance of the cognitive and
psychiatric symptoms and their impact on children’s lives,
as 69–86.7% of patients were academically delayed. In
evaluating the review, one should consider its main limi-
tations: (1) lack of standardised instruments to evaluate
psychiatric diagnosis in most studies; (2) a tendency to
include more severe patients in clinical series, resulting in
more maternal transmission cases than paternal ones
(Table 1); (3) the lack of a standardised cognitive evalua-
tion across series, except for the Wechsler intelligence
scale; and (4) the small sample size in most series.
The learning disabilities observed in DM1 patients could
be explained by at least two factors. First, patients with
0,000
0,010
0,020
0,030
0,040
0,050
40 50 60 70 80 90 100 110 120
Group 1
Mental Retardation
Mean IQ (±SD) = 58 (±9)
Group 2
Normal Intelligence
Mean IQ (±SD) = 91 (±13)
Fig. 2 Admixture analysis of
the observed distribution of IQ
scores in 36 patients with
juvenile myotonic dystrophy.
The likelihood ratio test
indicated that the model with
two distributions fit the
observed distribution of IQ
significantly better than the
model with one distribution
(v2 = 9.45, df = 3, P = 0.024).
No further improvement was
obtained with a three
component model. The mean IQ
scores estimated in this model
were 58 (±9) and 91 (±13)
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juvenile DM1 may have mental retardation or borderline
IQ. All studies found a significant effect on the length of
the CTG repeat on cognitive abilities, with a negative
correlation between the length of the CTG repeat expan-
sion and IQ scores (full scale, verbal and performance
subscales). A link between the transmission modes, with
maternal transmission creating a negative effect on IQ, was
also found. Although inheritance from the mother gave
systematically longer repeat lengths, the question of an
independent effect of the transmitting parent’s sex on IQ
still remains unclear. Second, even in patients with sub-
normal intelligence, some deficits were found in subtests of
the cognitive assessment: attention was frequently descri-
bed as impaired, but visual spatial and/or visual construc-
tive skills and verbal working memory could also be
disturbed. The attention deficit was diagnosed as a symp-
tom of the ADHD syndrome in 1/3 of the children. The
hypothesis of a specific cognitive impairment in DM1
children was reinforced by the results of the study on
learning disabilities by Cohen et al. [10]. This study found
that DM1 children and adolescents had impaired written
language skills, even in the absence of mental retardation;
in particular, they had spelling and reading impairments,
despite normal word identification. The severity of these
learning difficulties was correlated with longer mutation
length and maternal transmission, but could not be related
to a phonological deficit, which distinguished these chil-
dren from children with classical dyslexia. These difficul-
ties are probably increased by the oral motor dysfunction
and the impaired facial expression, as noticed in Sjo¨green’s
study [32], but are also likely secondary to a visual spatial
deficit and/or a motor coordination disorder.
The results of the cognitive assessment of juvenile DM1
patients are consistent with those found in patients with the
adult form of DM1. These adult patients showed impair-
ment in executive functions, attention deficit, abnormalities
in visual perception, constructional ability and visual
memory, following years of development of the disease;
and this was irrespective of their IQ score [33–36]. Adults
with DM1 also show mental retardation, but in a smaller
proportion of 10–25% [37]. Furthermore, IQ declines as the
age of DM1 onset decreases and the CTG expansions
increases [36, 38, 39]; although, IQ apparently does not
correlate with the neuromuscular impairment. The cogni-
tive defects are supported by neuropathological findings
and neuroimaging: (1) reduced cerebral perfusion in the
frontal and temporal lobes by H2O PET scan correlated
with cognitive impairment [40]; (2) a variety of abnor-
malities were discovered such as neurofibrillary tangles,
intracytoplasmic inclusions and subcortical white matter
lesions with a breakdown of myelin sheets, with relative
preservation of axons and the presence of fatty granular
cells [41–43]. No imaging study is currently available in
patients with the juvenile form of DM1. Finally, to our
knowledge, the association of advanced parental age with
low IQ in offspring [44] has never been tested in DM1
patients.
Our admixture analysis clarified significantly the
hypothesis of a cognitive impairment in the juvenile form of
DM1. Indeed, the analysis of IQ scores found a bimodal
distribution. Patients’ phenotypes were divided into two
groups: one group with mental retardation (IQ mean = 58),
with an overrepresentation of subjects whose mothers were
affected and one group without mental retardation, but with
borderline full scale IQ (IQ mean = 91) and more paternal
transmissions. In this latter group, VIQ is usually superior to
PIQ, due to a visual spatial deficit. Therefore, according
to the severity of the cognitive impairment, we propose to
distinguish two phenotypes in the juvenile form of DM1
(Table 3). The first group (with mental retardation) is
characterised by language and/or motor delay in infancy,
severe learning disabilities, possible vigilance impairments
including somnolence and maternal transmission. The sec-
ond group (with borderline full scale IQ) has subnormal
development, moderate learning disabilities, attention
and visual spatial deficits and more cases of paternal
transmission.
The study of psychiatric diagnoses of DM1 patients
showed that two-thirds of the children met criteria for at
least 1 axis 1 diagnosis: 1/3 of the children suffered from
ADHD and 1/4 of the children presented anxiety disorders.
Anxiety disorders were associated with other internalising
symptoms, such as withdrawal, phobia and social
Table 3 Distinguishing two phenotypes in the juvenile form of DM1
according to severity
Severe Mild
IQ Mild mental
retardation
Normal/borderline
Verbal
IQ [ Performance IQ
Development and
early signs
Hypotonia
Motor delay
Speech and language
delay
Subnormal
Motor coordination
disorder
Other cognitive
dysfunctions
Learning disabilities
Visual spatial deficit
Learning disabilities
Visual spatial deficit
Psychiatric signs ADHD
Somnolence
Anxiety and
depression
ADHD
Attention deficit
Anxiety and depression
Differential
diagnosis
Pervasive
developmental
disorders
Social phobia
Specific learning/
developmental disorder
Transmission Maternal Paternal
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interaction problems. In the adult form of DM1, patients
frequently exhibit (about 20%) an avoidant personality
disorder, characterised by social inhibition, anxiety and a
high sensitivity to criticism [45–47]. The question of a link
between withdrawal and anxiety disorders in childhood and
the development of a personality disorder in adulthood
should be explored. These anxious manifestations may be a
consequence of two different phenomena: first, as a sec-
ondary and nonspecific sign due to the child’s difficulty in
living with a severe, chronic and handicapping disease, but
also, secondly, as a possible consequence of motor coor-
dination disorder and visual spatial impairment. A link
between anxiety development and withdrawal style was
supported by studies in children with motor coordination
disorder, regardless of the cause [48]. It would, then, be
interesting to systematically assess the occurrence of motor
coordination disorder or visual spatial deficit in children
with DM1. Regarding the withdrawal symptoms, they
could be interpreted as a sign of social interaction difficulty
belonging to the autism spectrum. Two papers reported
cases of Asperger syndrome, and Ekstro¨m et al. found that
16.7% of patients with the juvenile form of DM1 had an
autistic disorder [27]. Furthermore, a deficit in facial
emotion recognition has also been described in adults with
DM1 [47]. However, we consider pervasive developmental
disorder as a differential diagnosis for DM1 (Case 1): (1)
Ekstro¨m et al. found a correlation between the occurrence
of autism/mental retardation and the severity of DM1; (2)
interpretation by parents of early social skills is difficult
due to affected infants’ hypotonia and amimic faces; (3)
speech and language delay is frequent, and a high score in
this dimension may not be specific; (4) no subject with
autism spectrum conditions (N = 28) in the Ekstro¨m study
had self-injurious behaviour. However, it may be possible
that DM1 offers a model, illustrating a continuum along
forms of DM1, for autistic disorders and severe social
anxiety. In the field of genetic disease, this is the case for
fragile X syndrome, with autism being associated with
affected males and social anxiety with affected females
[49].
The occurrence of ADHD, found in four studies to be
16–33%, with a majority of the inattentive subtype, raises
many questions. First, is there a link between attention
impairment and sleep/vigilance disorder? In fact, 38% of
children with juvenile DM1 present periodic limb move-
ments and 29% have sleep apnoea syndrome [26]. The
association between ADHD and sleep disorder was
described in ADHD children, for whom sleep apnoea dis-
orders and non-restless limb movements were described
[50]. Alternatively, sleep/vigilance disorders were also
observed in the adult form of DM1 after years of
development [51–53]. Second, is the diagnosis of ADHD
valid in DM1 children given the link between attention
deficit, vigilance problems and sleep disorders? ADHD
could be interpreted as a misdiagnosed form of a vigilance
problem. Conversely, vigilance problems could be a form
of severe attention deficit, or finally, we could also
hypothesise that both disorders share common underlying
mechanisms. This association suggests important thera-
peutic possibilities for psycho-stimulant drugs.
Regarding the therapeutic approach and research per-
spectives, we consider that children with juvenile DM1
deserve more specific research on treatments. First, stim-
ulant medication should be investigated for treating atten-
tion deficit and/or vigilance impairment. However, DM1 is
a poly-system disease including cardiac risk and this risk
needs to be specifically explored and monitored. Several
cases of cardiac arrhythmias, some resulting in sudden
death, have been reported [54] in young patients with
juvenile DM1. Therefore, amphetamines should be avoi-
ded; either atomoxetine or modafinil is preferred. Ato-
moxetine is a first-line agent in the treatment of ADHD for
both the American Academy of Child and Adolescent
Psychiatry [55] and the European Clinical Guidelines [56].
A recent pooled analysis of two long-term extension
studies following 16 short term trials and including 714
patients treated with atomoxetine for more than 3 years
showed reassuring data regarding cardiac tolerability and
safety [57]. Modafinil is not a first-line agent yet, but was
recently evaluated in a double-blind placebo controlled
trial in children with ADHD [58] and also in an open trial
for adults with DM1 who suffered from fatigue or som-
nolence [59]. Second, given the prevalence of learning
difficulties, language remediation and reading therapy
should be addressed as well. There is also a requirement for
further research in assessing the visual spatial deficits and
motor coordination disorder of children with juvenile
DM1.
In summary, the results presented herein suggest many
questions about the specificity of the observed symptoms,
as illustrated by two clinical studies. Case 1 shows the
importance of the cognitive impairment as well as the
possible secondary consequences of visual spatial diffi-
culties and motor coordination impairments on social
interaction. In addition, there is a probable deficit in
facial emotion recognition as described in adults [41].
The second case report describes the presence of symp-
toms clearly secondary to the disease (learning disabili-
ties and borderline efficiency), but also symptoms
secondary to the maladjustment to the disease during
adolescence (mythomanic inventions and depressive
symptoms).
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Case reports
Conclusion
Children with juvenile DM1 present a specific cognitive
and psychiatric profile characterised by attention deficit,
social anxiety, learning disabilities, visual spatial impair-
ments and motor coordination disorder. Two different
subtypes of juvenile DM1 can be distinguished, based on
CTG expansions and the transmitting parent: one group
characterised by mental retardation, severe developmental
delay and maternal transmission and a second group
characterised by borderline full scale IQ, subnormal
development and paternal transmission. Juvenile DM1
requires further research on therapeutic perspectives while
considering these various clinical aspects of the
phenotype.
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